4/A: GeneDx CFO Amends SEC Filing for RSU Acquisition

GeneDx Holdings Corp.'s CFO, Kevin Feeley, filed an amended Form 4 to correct a typographical error regarding the acquisition of 7,197 Class A Common Stock shares from RSU vesting.

Summary

• Kevin Feeley, Chief Financial Officer of GeneDx Holdings Corp., filed an amended Form 4 (Form 4/A).
• The amendment corrects a typographical error in a Form 4 originally filed on September 18, 2025.
• The original filing inadvertently listed a 'D' (disposition) code in Table I, column 4, for a transaction.
• The corrected transaction code is 'A' (acquisition), accurately reflecting the vesting of restricted stock units (RSUs).
• On September 16, 2025, Mr. Feeley acquired 7,197 shares of Class A Common Stock through RSU vesting at a price of $0.
• Following this transaction, Mr. Feeley beneficially owns 12,483 shares of Class A Common Stock.
• Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

Sentiment

Score: 5

Explanation: The filing is neutral as it primarily corrects a typographical error in a previously reported insider transaction. The underlying transaction (RSU vesting) is generally positive for the executive, but the amendment itself is administrative.

Positives

• The vesting of 7,197 restricted stock units (RSUs) for Kevin Feeley, the Chief Financial Officer, represents an increase in his direct ownership in the company.
• The acquisition of shares at a $0 price indicates these were compensation-related awards, aligning management's interests with shareholders.

Negatives

• The need for an amendment due to a typographical error in the original filing indicates a minor administrative oversight in reporting.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Industry Context

This filing is an amendment to an insider transaction report and does not provide information relevant to broader industry trends or competitive landscape analysis.

Stakeholder Impact

• Shareholders: The amendment clarifies the nature of an insider transaction, ensuring accurate public record of executive ownership. The underlying RSU vesting aligns management incentives with shareholder value.
• Management: Kevin Feeley's beneficial ownership in the company increases, strengthening his alignment with company performance.

Key Dates

Keywords

GeneDx Holdings Corp., WGS, Kevin Feeley, CFO, Form 4/A, SEC filing, insider transaction, restricted stock units, RSU vesting, stock acquisition, beneficial ownership